Effects of Rehabilitation for Patients With Obstructive Sleep Apnea

Status Completed

Clinical Trial Summary

In previous review study, it was hypothesized that a comprehensive rehabilitation can combine both local pharyngeal muscle exercise and systemic cardiopulmonary rehabilitation for the OSA patients with oropharyngeal muscle dysfunction or ventilator drive instability. To develop a comprehensive rehabilitation model is of innovative care strategy in this study.

Clinical Trial Description

BACKGROUND: Obstructive sleep apnea (OSA) is a prevalent sleep-related breathing disorder, which was characterized by repetitive events of complete and partial obstructions of the upper airway. The pathogenesis of OSA is interacted by multiple factors, primarily including upper airway (UA) anatomic impairment, ventilatory drive instability, and oropharyngeal muscle dysfunction. However, studies have proven prior oropharyngeal exercise was designed for those OSA patients with oropharyngeal muscle dysfunction. Unlike prior oropharyngeal exercise, comprehensive rehabilitation should emphasize the cardiorespiratory regulation capability in addition to oropharyngeal function.

OBJECTIVES: Therefore, the purpose of this study is to explore both the clinical and biological effects of our comprehensive rehabilitation, we used PSG data as clinical effect and biomarker of inflammation expression as biological effect.

METHODS: Thirty subjects with moderate or severe OSA (AHI≥15) were randomized into intervention group (N=15) and control group (N=15). In intervention group, a 12-week-intervention of out-patient rehabilitation program included oropharyngeal muscle training, threshold respiratory muscle training, and therapeutic exercise.

ANTICIPATED OUTCOMES: The preliminary results would demonstrate promisingly clinical effects and biological effects of our comprehensive rehabilitation model. Therefore, the further studies should emphasize the methods to differentiate diagnosis for the indicated patients with oropharyngeal muscle dysfunction or ventilatory drive instability. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03940781
Study type	Interventional
Source	National Cheng-Kung University Hospital
Contact
Status	Completed
Phase	N/A
Start date	September 1, 2017
Completion date	March 22, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05489562` - Use of Intraoral Suction and Its Effects on Obstructive Sleep Apnea	N/A
Recruiting	`NCT05717959` - Efficacy of Oropharyngeal Exercises for Patients With Obstructive Sleep Apnea Using Mandibular Advancement Device	N/A
Recruiting	`NCT06008626` - Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea	N/A
Completed	`NCT03122639` - Endothelial Function in Obstructive Sleep Apnea	Early Phase 1
Recruiting	`NCT05289063` - Vascular Endothelial Dysfunction in Sleep Apnea	Phase 1
Not yet recruiting	`NCT05268471` - Cost-effectiveness Analysis and Conditional Response to the Effect of Positional Devices in Obstructive Sleep Apnea	N/A
Active, not recruiting	`NCT04864652` - Safety and Dosing Study of the CHILLS Cryotherapy for the Treatment of OSA	N/A
Enrolling by invitation	`NCT05433883` - The Relationship Between Obstructive Sleep Apnea and Alzheimer's Disease: Evidence and Effectiveness	N/A
Recruiting	`NCT06103630` - Efficacy of Oropharyngeal Exercises for Patients With Obstructive Sleep Apnea Using Mandibular Advancement Device	N/A
Recruiting	`NCT06283095` - Management of Obstructive Sleep Apnea Syndrome by Expansion Palatoplasty	N/A
Completed	`NCT03156283` - SleepWell24: An Innovative Smartphone Application to Improve PAP Adherence	N/A
Completed	`NCT03362385` - OSA-ACS Project: Association of OSA and CPAP Therapy With Outcomes in ACS Patients
Recruiting	`NCT06447818` - Changes in Difficult Airway Markers After Surgery for Obstructive Sleep Apnoea Syndrome
Completed	`NCT04643782` - Comparative Study of the ANNE™ One System to Diagnose Obstructive Sleep Apnea	N/A
Recruiting	`NCT03463785` - Does Race Make a Difference in Obstructive Sleep Apnea?
Recruiting	`NCT03618719` - Impact of Intermittent Hypoxia on the Function of the Phagocytes
Completed	`NCT03048604` - BiLAteral Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnoea (BLAST OSA)	N/A
Recruiting	`NCT05290350` - Long COVID-19 Fatigue and Obstructive Sleep Apnea
Recruiting	`NCT05739617` - Comprehensive Respiratory Training Exercise Program in Obstructive Sleep Apnea	N/A
Completed	`NCT03980158` - Change in Tongue Strength and Fatigue After Upper Airway Stimulation Therapy

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.